These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25159076)

  • 1. Phosphodiesterases as therapeutic targets for Huntington's disease.
    Fusco FR; Giampà C
    Curr Pharm Des; 2015; 21(3):365-77. PubMed ID: 25159076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Phosphodiesterases in Huntington's Disease.
    Fusco FR; Paldino E
    Adv Neurobiol; 2017; 17():285-304. PubMed ID: 28956337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of phosphodiesterases as a strategy to achieve neuroprotection in Huntington's disease.
    Cardinale A; Fusco FR
    CNS Neurosci Ther; 2018 Apr; 24(4):319-328. PubMed ID: 29500937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphodiesterase 10A (PDE10A) localization in the R6/2 mouse model of Huntington's disease.
    Leuti A; Laurenti D; Giampà C; Montagna E; Dato C; Anzilotti S; Melone MA; Bernardi G; Fusco FR
    Neurobiol Dis; 2013 Apr; 52():104-16. PubMed ID: 23220622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the striatal specific phosphodiesterase PDE10A ameliorates striatal and cortical pathology in R6/2 mouse model of Huntington's disease.
    Giampà C; Laurenti D; Anzilotti S; Bernardi G; Menniti FS; Fusco FR
    PLoS One; 2010 Oct; 5(10):e13417. PubMed ID: 20976216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PDE10 inhibition increases GluA1 and CREB phosphorylation and improves spatial and recognition memories in a Huntington's disease mouse model.
    Giralt A; Saavedra A; Carretón O; Arumí H; Tyebji S; Alberch J; Pérez-Navarro E
    Hippocampus; 2013 Aug; 23(8):684-95. PubMed ID: 23576401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation of synaptic proteins, dendritic spine abnormalities and pathological plasticity of synapses as experience-dependent mediators of cognitive and psychiatric symptoms in Huntington's disease.
    Nithianantharajah J; Hannan AJ
    Neuroscience; 2013 Oct; 251():66-74. PubMed ID: 22633949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive Dysfunction in Huntington's Disease: Humans, Mouse Models and Molecular Mechanisms.
    Giralt A; Saavedra A; Alberch J; Pérez-Navarro E
    J Huntingtons Dis; 2012; 1(2):155-73. PubMed ID: 25063329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Pathogenesis in Huntington's Disease.
    Illarioshkin SN; Klyushnikov SA; Vigont VA; Seliverstov YA; Kaznacheyeva EV
    Biochemistry (Mosc); 2018 Sep; 83(9):1030-1039. PubMed ID: 30472941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggregation of scaffolding protein DISC1 dysregulates phosphodiesterase 4 in Huntington's disease.
    Tanaka M; Ishizuka K; Nekooki-Machida Y; Endo R; Takashima N; Sasaki H; Komi Y; Gathercole A; Huston E; Ishii K; Hui KK; Kurosawa M; Kim SH; Nukina N; Takimoto E; Houslay MD; Sawa A
    J Clin Invest; 2017 Apr; 127(4):1438-1450. PubMed ID: 28263187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat.
    Clemens LE; Weber JJ; Wlodkowski TT; Yu-Taeger L; Michaud M; Calaminus C; Eckert SH; Gaca J; Weiss A; Magg JC; Jansson EK; Eckert GP; Pichler BJ; Bordet T; Pruss RM; Riess O; Nguyen HP
    Brain; 2015 Dec; 138(Pt 12):3632-53. PubMed ID: 26490331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of Phospho-CREB by Systemically Administered Recombinant BDNF in the Hippocampus of the R6/2 Mouse Model of Huntington's Disease.
    Paldino E; Giampà C; Montagna E; Angeloni C; Fusco FR
    Neurosci J; 2019; 2019():8363274. PubMed ID: 30881980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term memory deficits in Huntington's disease are associated with reduced CBP histone acetylase activity.
    Giralt A; Puigdellívol M; Carretón O; Paoletti P; Valero J; Parra-Damas A; Saura CA; Alberch J; Ginés S
    Hum Mol Genet; 2012 Mar; 21(6):1203-16. PubMed ID: 22116937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mGluR5 positive allosteric modulator, CDPPB, ameliorates pathology and phenotypic signs of a mouse model of Huntington's disease.
    Doria JG; de Souza JM; Andrade JN; Rodrigues HA; Guimaraes IM; Carvalho TG; Guatimosim C; Dobransky T; Ribeiro FM
    Neurobiol Dis; 2015 Jan; 73():163-73. PubMed ID: 25160573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Huntington's disease: clinical and molecular genetics].
    Warita H; Shiro Y; Kashihara K; Abe K
    Nihon Rinsho; 1999 Apr; 57(4):896-9. PubMed ID: 10222786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Huntington's disease: novel therapeutic perspectives hanging in the balance.
    Saavedra A; García-Díaz Barriga G; Pérez-Navarro E; Alberch J
    Expert Opin Ther Targets; 2018 May; 22(5):385-399. PubMed ID: 29671352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azadiradione Restores Protein Quality Control and Ameliorates the Disease Pathogenesis in a Mouse Model of Huntington's Disease.
    Singh BK; Vatsa N; Nelson VK; Kumar V; Kumar SS; Mandal SC; Pal M; Jana NR
    Mol Neurobiol; 2018 Aug; 55(8):6337-6346. PubMed ID: 29294248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Huntington's Disease: Relationship Between Phenotype and Genotype.
    Sun YM; Zhang YB; Wu ZY
    Mol Neurobiol; 2017 Jan; 54(1):342-348. PubMed ID: 26742514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opportunities and perspectives of small molecular phosphodiesterase inhibitors in neurodegenerative diseases.
    Li Q; Liao Q; Qi S; Huang H; He S; Lyu W; Liang J; Qin H; Cheng Z; Yu F; Dong X; Wang Z; Han L; Han Y
    Eur J Med Chem; 2024 May; 271():116386. PubMed ID: 38614063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphodiesterase 10 inhibition reduces striatal excitotoxicity in the quinolinic acid model of Huntington's disease.
    Giampà C; Patassini S; Borreca A; Laurenti D; Marullo F; Bernardi G; Menniti FS; Fusco FR
    Neurobiol Dis; 2009 Jun; 34(3):450-6. PubMed ID: 19281846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.